kang sungtaek

kang sungtaek

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JLJaeseong Lee
Jaeseong Lee
KSkang sungtaek
kang sungtaek
HPHyeseon Park
Hyeseon Park
JSJeong Gil Sun
Jeong Gil Sun
EKEun Chae Kim
Eun Chae Kim
Gayong ShimGayong Shim
Gayong Shim
Lymph nodes are organs that control immune cells and provide a major pathway for primary tumors to metastasize. A nanoparticles-based strategy has several advantages that make it suitable for achieving effective lymphatic delivery. First, the size of nanoparticles can be tailored to meet a size range appropriate for lymphatic migration. In addition, functionalized nanoparticles can target cells of interest for delivery of drugs or imaging probes. Existing lymph node contrast agents map all lymph nodes regardless of metastasis status; however, by using nanoparticles, it is possible to selectively target lymphatic metastases. Moreover, using functionalized nanoparticles, it is possible to specifically deliver anticancer drugs to metastatic lymph nodes. In this review, we introduce the use of nanoparticles for lymphatic mapping, in particular highlighting design considerations for detecting metastatic lymph nodes. Furthermore, we assess trends in lymph node-targeting nanoparticles in clinical practice and suggest future directions for lymph node-targeting nanoparticles.

24 August 2022 in Biomaterials
Verified
Journal Article
Closed access
JLJaiwoo Lee
Jaiwoo Lee
QLQuoc-Viet Le
Quoc-Viet Le
SKSeungbeom Ko
Seungbeom Ko
KSkang sungtaek
kang sungtaek
RMRobert B. Macgregor
Robert B. Macgregor
YOYu-Kyoung Oh
Yu-Kyoung Oh